Drawing for DERMAX

USPTO serial 78308807

DERMAX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KAZAZIAN, MICHAEL H
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with DERMAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOHN M LUCAS

DRINKER BIDDLE & REATH LLPNORM D ST LANDAU1500 K ST NW STE 1100WASHINGTON, DC 20005-1209

Goods and services

ClassDescriptionStatusFirst use
005Transdermal and topical pharmaceutical preparations for humans and animals for the treatment of cardiovascular, viral, bacterial, fungal, inflammatory, circulatory, respiratory, bone, neoplastic, malignant, allergic, convulsant, hypertensive, pain, parasitic, stomach, central nervous system, peripheral nervous system, psychotic, glycemic, muscle or a brain disorder or diseaseABANDONED—
042Human and animal transdermal and topical pharmaceutical drug research and development servicesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2005MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Dec 2, 2005ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 31, 2005OP.TOPPOSITION TERMINATED NO. 999999—
Oct 31, 2005OP.DOPPOSITION DISMISSED NO. 999999—
Jul 30, 2005OP.IOPPOSITION INSTITUTED NO. 999999—
May 23, 2005OP.IOPPOSITION INSTITUTED NO. 999999—
May 13, 2005DMCCDATA MODIFICATION COMPLETED—
Mar 25, 2005MAILPAPER RECEIVED—
Feb 3, 2005ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 18, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 29, 2004NPUBNOTICE OF PUBLICATION—
Nov 18, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 17, 2004ALIEASSIGNED TO LIE—
Nov 3, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 2, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 13, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 13, 2004FAXXFAX RECEIVED—
Sep 22, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 15, 2004GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2004DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance